Acrinova AB (publ)

SSE:ACRI-B.ST

7.96 (SEK) • At close February 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SEK.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q4
Revenue 39.8939.76738.82238.32636.4935.27133.78837.67432.27231.34729.2425.44725.16122.57628.77229.43425.83127.53826.64824.1324.87823.76421.30222.56920.67422.80921.59120.07621.07923.83418.84815.77311.2554.2420.2825.1690.0010.092.6871.167
Cost of Revenue 8.99612.77212.49412.0158.05611.02213.66712.5628.5679.95210.0188.6365.0766.978.6588.5175.9178.577.5998.0389.3885.4166.4246.5365.017.0347.07206.7846.5356.4540000000-0.090
Gross Profit 30.89426.99526.32826.31128.43424.24920.12125.11223.70521.39519.22216.81120.08515.60620.11420.91719.91418.96819.04916.09215.4918.34814.87816.03315.66415.77514.51920.07614.29517.29912.39415.77311.2554.2420.2825.1690.0010.092.7771.167
Gross Profit Ratio 0.7740.6790.6780.6870.7790.6880.5960.6670.7350.6830.6570.6610.7980.6910.6990.7110.7710.6890.7150.6670.6230.7720.6980.710.7580.6920.67210.6780.7260.65811111111.0331
Reseach & Development Expenses 0000000000000000000000000000000000000000
General & Administrative Expenses 05.0524.991-12.576.8977.9587.467-8.0666.3969.4619.093-15.8758.2559.00813.202-20.88612.24511.09512.49-18.8729.93811.4139.903-15.9878.4959.6539.148-17.6287.86611.6827.0578.2535.541.9660.211.0740.1850.3680.880.333
Selling & Marketing Expenses 0000000000000000000000000000000000000000
SG&A 05.0524.991-9.3226.8977.9587.467-5.9866.3969.4619.093-12.78.2559.00813.202-16.13512.24511.09512.49-13.4439.93811.4139.903-12.9648.4959.6539.148-14.5057.86611.6827.0578.2535.541.9660.211.0740.1850.3680.880.333
Other Expenses -4.326-5.052-4.991-7.857-6.897-7.958-0.66319.387-6.396-9.461021.0140-9.008-13.20230.94900027.39400025.0930006.0136.7846.5356.4545.6695.0931.7860.1400.1760.3220.640.617
Operating Expenses -4.3264.6254.9917.8576.1586.1526.80413.4016.3969.4619.0938.3148.2559.00813.20214.81412.24511.09512.4913.9519.93811.4139.90312.1298.4959.6539.148-8.49214.6518.21713.51113.92210.6333.7520.351.0740.3610.691.520.95
Operating Income 26.56821.94321.33718.45429.17326.05520.78425.11223.70421.39519.22216.8120.08515.60520.11420.91619.91418.96819.0492.14115.4918.34814.87816.03315.66415.77514.51915.10714.29517.29912.39410.1040.6220.49-0.0685.169-0.36-0.61.2570.217
Operating Income Ratio 0.6660.5520.550.4820.7990.7390.6150.6670.7350.6830.6570.6610.7980.6910.6990.7110.7710.6890.7150.0890.6230.7720.6980.710.7580.6920.6720.7520.6780.7260.6580.6410.0550.116-0.2411-360-6.6670.4680.186
Total Other Income Expenses Net -7.351-8.69-7.083-43.083-19.684-14.403-28.263-23.043-1.39719.6218.87214.59572.49926.2462.40812.274-11.03-15.238-9.32917.14-7.706-4.062-5.931-2.233-4.677-7.181-6.98-1.21323.083-12.593-10.178-25.025-0.436-0.125-0.095-4.381026.294-0.446-0.541
Income Before Tax 19.21713.25314.254-24.6299.48911.652-7.4792.06922.30741.01538.09431.40592.58441.85122.52233.198.8843.739.7219.2817.78414.2868.94713.810.9878.5947.53913.89437.3784.7062.216-14.9213.5831.397-0.1630.788-0.3625.6940.811-0.324
Income Before Tax Ratio 0.4820.3330.367-0.6430.260.33-0.2210.0550.6911.3081.3031.2343.681.8540.7831.1280.3440.1350.3650.7990.3130.6010.420.6110.5310.3770.3490.6921.7730.1970.118-0.9460.3180.329-0.5780.152-360285.4890.302-0.278
Income Tax Expense 4.2262.98712.029-9.8133.526-4.336-7.592-2.8776.26710.07710.6826.00120.5258.3240.3517.9252.5850.2062.0692.3861.9912.8382.092.7841.5471.5491.5133.1528.4240.4850.397-3.7440.3020.0980.0950.557-0.36-26.4910.210.037
Net Income 12.7649.512.032-14.35.96315.9880.1134.94616.0430.93927.41125.40572.05933.52822.1725.2676.2993.5247.65116.8955.79311.4486.85711.0169.447.0456.10510.76728.8374.0961.811-11.1873.2711.299-0.1630.231-0.3625.6940.601-0.361
Net Income Ratio 0.320.2390.052-0.3730.1630.4530.0030.1310.4970.9870.9370.9982.8641.4850.7710.8580.2440.1280.2870.70.2330.4820.3220.4880.4570.3090.2830.5361.3680.1720.096-0.7090.2910.306-0.5780.045-360285.4890.224-0.309
EPS 0.190.140.03-0.210.0870.230.0020.0760.250.480.420.321.220.690.530.590.150.0890.170.540.180.380.230.370.310.240.20.370.990.150.064-0.410.130.067-0.0210.03-0.0453.250.077-0.046
EPS Diluted 0.190.140.03-0.210.0870.230.0020.0760.250.470.420.321.220.690.530.590.150.0890.170.540.180.380.230.370.310.240.20.370.990.150.064-0.410.130.067-0.0210.03-0.0453.250.077-0.046
EBITDA 26.56828.12318.72618.69915.9834.559.3699.24419.80826.69223.59734.84493.19240.62122.56335.68611.8298.0416.26918.35710.2615.88110.43115.12312.47210.4538.73915.14839.9436.0998.0467.1975.6512.134-0.0151.421-0.3625.8911.7650.834
EBITDA Ratio 0.6660.7070.4820.4880.4380.1290.2770.2450.6140.8520.8071.3693.7041.7990.7841.2120.4580.2920.6110.7610.4120.6680.490.670.6030.4580.4050.7551.8950.2560.4270.4560.5020.503-0.0520.275-360287.6780.6570.715